ROHTO PHARMACEUTICAL CO revenue for the last year amounted to 270.84 B JPY, the most of which — 176.82 B JPY — came from its highest performing source at the moment, Skin Care, the year earlier bringing 156.66 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought ROHTO PHARMACEUTICAL CO 156.85 B JPY, and the year before that — 136.67 B JPY.